Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir Vs Paritaprevir/Ritonavir/Ombitasvir With Dasabuvir In Treatment Of Chronic Hepatitis C In The Russian Federation
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.400
https://www.valueinhealthjournal.com/article/S1098-3015(16)31767-3/fulltext
Title :
Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir Vs Paritaprevir/Ritonavir/Ombitasvir With Dasabuvir In Treatment Of Chronic Hepatitis C In The Russian Federation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31767-3&doi=10.1016/j.jval.2016.09.400
First page :
A415
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
371